Mazdutide
This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
Innovent · Phase 1 · Completed · Enrollment 36
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 362-dose1-4mg | Obesity or overweight | 4mg | 12 | n/r | n/r |
| 362-dose2-6mg | Obesity or overweight | 6mg | 12 | n/r | n/r |
| 362-dose3-Placebo | Obesity or overweight | n/r | 12 | n/r | n/r |